LYMPHOTROPIC PROTECTIVE SURFACTANT THERAPY IN PATIENTS WITH PULMONARY TUBERCULOSIS
The aim of the study was to increase the efficiency of the treatment of patients with destructive infiltrative pulmonary tuberculosis by promoting limfointerstitsial relationships through correction of metabolic lung surfactant system. Patients with infiltrative form of pulmonary tuberculosis in a phase of decay was administered isoniazid lymphotropic in solution with pH 7.4 the upper and lower retrosternal access and parasternal. Before and after 2 months of treatment in the bronchoalveolar lavage estimated range of phospholipids in pulmonary surfactant. During chemotherapy, received a partial rebalancing of phospholipids pulmonary surfactant, the most successful in patients with lymphotropic administration of isoniazid. This is partly explained by a more pronounced clinical benefit in patients who have received a course of indirect endolymphatic chemotherapy.